Hong Kong-listed innovative pharmaceutical stocks continued to rise, with BeiGene Ltd. up nearly 10%.
Hong Kong-listed innovative pharmaceutical concept stocks continued to rise, with BeiGene-B up nearly 10%, Sino Biopharmaceutical, Sino Biopharmaceutical, Nuocai Health, and China Biopharma Biopharma leading the gains.
Latest